Cancer-derived extracellular vesicles in natural killer cell immune evasion: Molecular mechanisms and therapeutic

Elaina Coleborn1, Raluca Ghebosu2, Joy Wolfram3

  • 1Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD 4102, Australia.

Insights

Cancer cells release extracellular vesicles that suppress natural killer (NK) cells, hindering cancer immunosurveillance. This review explores NK cell suppression by cancer extracellular vesicles and therapeutic strategies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Natural killer (NK) cells are crucial innate immune cells for identifying and eliminating cancer cells.
  • Cancer cells exploit extracellular vesicles (EVs) to create an immunosuppressive tumor microenvironment, impairing NK cell function.
  • Cancer-derived EVs suppress NK cell activity by inhibiting cytolytic proteins and downregulating key receptors.

Purpose of the Study:

  • To review the current understanding of interactions between cancer-derived EVs and NK cells.
  • To elucidate the mechanisms by which EVs induce NK cell immunosuppression.
  • To discuss the implications for developing novel cancer immunotherapies targeting NK cell dysfunction.

Main Methods:

  • Literature review of studies investigating cancer-EVs and NK cell interactions.
  • Analysis of mechanisms underlying NK cell dysfunction induced by cancer EVs.
  • Synthesis of information on therapeutic strategies to restore NK cell anti-tumor activity.

Main Results:

  • Cancer-derived EVs impair NK cell-mediated killing, survival, proliferation, migration, and metabolism.
  • EVs from various cancer types (e.g., leukemia, melanoma, lung, breast) exhibit immunosuppressive properties.
  • NK cell suppression by EVs represents a significant barrier to effective cancer immunosurveillance.

Conclusions:

  • Cancer-derived EVs are potent mediators of immune suppression, specifically targeting NK cells.
  • Targeting EV-mediated NK cell suppression offers a promising avenue for enhancing cancer immunotherapy.
  • Further research is needed to fully understand these interactions and develop effective therapeutic interventions.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
3.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K